Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Medosome Biotec is a clinical-stage biotechnology company focused on developing innovative therapies for rare diseases, gastrointestinal disorders, and metabolic conditions. The company leverages its proprietary Lactobacillus-based platform (LBP) for the oral delivery of peptides and proteins, such as GLP-1, and is advancing a pipeline that includes small molecules for Pyruvate Dehydrogenase Complex Deficiency (PDCD) and demyelinating diseases. Medosome also commercializes GI health products through its subsidiary, Nuteric Natural Health Products, and supports global health initiatives through its non-profit arm, Gifting Health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gifting Health.